Capricor
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Capricor and other ETFs, options, and stocks.About CAPR
Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine.
CAPR Key Statistics
Stock Snapshot
The current Capricor(CAPR) stock price is $3.86, with a market capitalization of 222.39M. The stock trades at a price-to-earnings (P/E) ratio of -1.81.
During the trading session on 2026-07-31, Capricor(CAPR) shares reached a daily high of $4.66 and a low of $3.80. At a current price of $3.86, the stock is +1.6% higher than the low and still -17.2% under the high.
Trading volume for Capricor(CAPR) stock has reached 7.29M, versus its average volume of 8.68M.
The stock's 52-week range extends from a low of $2.96 to a high of $40.37.
The stock's 52-week range extends from a low of $2.96 to a high of $40.37.
CAPR News
...
Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions Subscribe to TipRanks Smart Investor Newsletter, and...
Capricor Therapeutics (CAPR) announced that the U.S. Food and Drug Administration’s Cellular, Tissue and Gene Therapies Advisory Committee voted that available...
Analyst ratings
100%
of 10 ratingsMore CAPR News
Capricor Therapeutics (CAPR) announced that The Lancet has published results from the Company’s pivotal Phase 3 HOPE-3 clinical trial evaluating Deramiocel, its...
In July 2026, Capricor Therapeutics disclosed that FDA reviewers found no statistically significant benefit for its Duchenne muscular dystrophy cell therapy Der...
‘Pharma Bro’ Martin Shkreli is publicly accusing Capricor Therapeutics (NASDAQ:CAPR) of fraud and alleging legal action will be taken against its CEO and a cons...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.